The ongoing struggle against drug trafficking and organized crime remains a complex issue with significant cross-border implications, as highlighted by Mexican President Claudia Sheinbaum’s recent response to criticism from US President Donald Trump. Sheinbaum emphasized Mexico’s commitment to addressing these challenges while underscoring the need for the United States to examine its own role in the drug crisis that affects both nations.
In a press conference, Sheinbaum responded to Trump’s comments by defending Mexico’s efforts to combat corruption and drug-related crime, asserting that her government is actively pursuing measures against these issues. She highlighted that Mexico is accountable for its own actions and does not require external judgment. Furthermore, Sheinbaum called for increased scrutiny of the United States’ efforts to combat drug trafficking, money laundering, and the illegal flow of arms into Mexico.
Sheinbaum pointed out that the illegal flow of firearms from the United States significantly contributes to the power of criminal organizations in Mexico. She questioned the US government’s measures to address this issue, as well as efforts to tackle domestic drug consumption and opioid addiction, which have far-reaching impacts on the drug trade dynamics across the border.
While acknowledging the severity of drug production and trafficking problems within Mexico, Sheinbaum stressed that this is a shared responsibility. She defended her administration’s record, citing initiatives like Operation Swarm, which targets criminal and corruption networks, and the prosecution of officials suspected of cartel connections, irrespective of political ties.
In response to Trump’s administration’s calls for increased action from Mexico, Sheinbaum reiterated her government’s proactive stance on prosecuting corrupt officials when evidence is present. She also urged the United States to be more transparent about its strategies to combat fentanyl trafficking and drug consumption, suggesting that both nations must confront their respective roles in the ongoing drug crisis.